Brief: An2 Therapeutics Announces Pricing Of $70.0 Million Underwritten Offering Of Common Stock
16/08/2023 03:43
Aug 15 (Reuters) - AN2 Therapeutics Inc ANTX.O :
* AN2 THERAPEUTICS ANNOUNCES PRICING OF $70.0 MILLION
UNDERWRITTEN
OFFERING OF COMMON STOCK
* AN2 THERAPEUTICS - PRICING OF AN UNDERWRITTEN OFFERING OF
7.8
MILLION SHARES OF ITS COMMON STOCK AT A PRICE OF $9.00 PER SHARE
Source text for Eikon: ID:nBw2fnn9Xa
Further company coverage: ANTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AN2 Therapeutics
See all newsBrief: AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(C)(4)
Brief: An2 Therapeutics Announces Extension Of Funding For Tuberculosis Research Collaboration With Gsk
AN2 Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
AN2 Therapeutics Q2 net loss widens on higher R&D costs
AN2 Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview